Literature DB >> 9449425

Behavioural and electrophysiological evidence supporting a role for group I metabotropic glutamate receptors in the mediation of nociceptive inputs to the rat spinal cord.

M R Young1, S M Fleetwood-Walker, T Dickinson, G Blackburn-Munro, H Sparrow, P J Birch, C Bountra.   

Abstract

A combined study of behavioural and electrophysiological tests was carried out in order to assess the role of metabotropic glutamate receptors (mGluRs) in mediating sensory inputs to the spinal cord of the rat. In the behavioural study the responses of conscious animals, with or without carrageenan-induced inflammation, to noxious mechanical and thermal stimuli were observed both before and after the intrathecal administration of mGluR antagonists L(+)-2-amino-3-phosphonopropionic acid (L-AP3) and (S)-4-carboxy-3-hydroxyphenylglycine (CHPG). It was found that the mGluR antagonist (S)-CHPG was capable of increasing both mechanical threshold and thermal latency in both groups of animals, and L-AP3 did so in those with inflammation induced in their hindpaw. Following this study, the responses of single lamina III-V dorsal horn neurons to an innocuous A beta fibre brush stimulus and a noxious C fibre (mustard oil) stimulus were extracellularly recorded and the effect of ionophoretically applied drugs was examined. Cyclothiazide (CTZ), a selective antagonist at mGluR1, markedly reduced the activity evoked by mustard oil, but not that elicited by brushing of the receptive field. Activity induced in dorsal horn neurons by ionophoresing various mGluR subgroup agonists was examined. CTZ successfully inhibited the activity evoked by group I mGluR agonist 3,5-dihydroxyphenylglycine (DHPG). In comparison to the neurons which responded to the ionophoresis of DHPG, less were activated by the selective mGluR5 agonist trans-azetidine dicarboxylic acid (t-ADA). Together these results indicate that group I mGlu receptors, in particular mGluR1, play a crucial role in mediating nociception, particularly following a sustained noxious input.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9449425

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Metabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing.

Authors:  E Palazzos; V de Novellis; I Marabese; F Rossi; S Maione
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

2.  Metabotropic glutamate receptor 5 regulates excitability and Kv4.2-containing K⁺ channels primarily in excitatory neurons of the spinal dorsal horn.

Authors:  Hui-Juan Hu; Robert W Gereau
Journal:  J Neurophysiol       Date:  2011-03-30       Impact factor: 2.714

3.  Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats.

Authors:  M E Fundytus; K Yashpal; J G Chabot; M G Osborne; C D Lefebvre; A Dray; J L Henry; T J Coderre
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

4.  Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist.

Authors:  O El-Kouhen; S G Lehto; J B Pan; R Chang; S J Baker; C Zhong; P R Hollingsworth; J P Mikusa; E A Cronin; K L Chu; S P McGaraughty; M E Uchic; L N Miller; N M Rodell; M Patel; P Bhatia; M Mezler; T Kolasa; G Z Zheng; G B Fox; A O Stewart; M W Decker; R B Moreland; J D Brioni; P Honore
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

Review 5.  Alcoholic neuropathy: possible mechanisms and future treatment possibilities.

Authors:  Kanwaljit Chopra; Vinod Tiwari
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

Review 6.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

7.  Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L: -DOPA-induced dyskinesia.

Authors:  Andrzej Dekundy; Andreas Gravius; Mirko Hechenberger; Małgorzata Pietraszek; Jens Nagel; Carsten Tober; Martine van der Elst; Flora Mela; Christopher G Parsons; Wojciech Danysz
Journal:  J Neural Transm (Vienna)       Date:  2010-12-16       Impact factor: 3.575

8.  Antisense ablation of type I metabotropic glutamate receptor mGluR1 inhibits spinal nociceptive transmission.

Authors:  M R Young; G Blackburn-Munro; T Dickinson; M J Johnson; H Anderson; I Nakalembe; S M Fleetwood-Walker
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

Review 9.  Central sensitization: a generator of pain hypersensitivity by central neural plasticity.

Authors:  Alban Latremoliere; Clifford J Woolf
Journal:  J Pain       Date:  2009-09       Impact factor: 5.820

10.  mGluR5 antagonists that block calcium mobilization in vitro also reverse (S)-3,5-DHPG-induced hyperalgesia and morphine antinociceptive tolerance in vivo.

Authors:  Bichoy H Gabra; Forrest L Smith; Hernán A Navarro; F Ivy Carroll; William L Dewey
Journal:  Brain Res       Date:  2007-10-12       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.